£10 Million Prize to Focus on Antibiotic Resistance

The British public votes to make creating a better test for bacterial infections the goal of the UK government’s Longitude Prize.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

MRSA is just one of many antibiotic-resistant strains of bacteria threatening human health.WIKIMEDIA, CDCResearch teams will vie for the £10 million ($17 million) Longitude Prize, a new award funded by the United Kingdom government and innovation charity Nesta, by developing a “cost-effective, accurate, rapid and easy-to-use test for bacterial infections that will allow health professionals worldwide to administer the right antibiotics at the right time,” according to the prize’s website. BBC science presenter Alice Roberts announced the winning focus, which the British public voted for among five other categories, on the BBC’s “One Show” on Wednesday (June 25). “There were some amazing challenges,” she said of the other categories, which included flight, food, paralysis, water, and dementia. “But this is such an important one facing us at the moment.”

Antibiotic resistance has been building in the human population for years, and scientists have been racing to develop new, more-effective antibiotics to keep pace. “Identifying innovative and ground-breaking solutions to the problems of antimicrobial resistance are not only needed but are essential,” said Nicholas Brown, president of the British Society for Antimicrobial Chemotherapy, in a statement. “The Longitude Prize is a high-profile opportunity to ensure the issue of antimicrobial resistance stays high on all agenda—healthcare, public, and political.”

Astronomer Martin Rees, who is the chairman of the Longitude Committee, wrote in Nature last month (May 20) that he hoped the prize would encourage further investment after a winner was named in five years. “A well-designed prize should unleash investment from many quarters, amounting to much ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies